dc.contributor.author |
Mahesh, R. |
|
dc.date.accessioned |
2023-11-23T05:57:08Z |
|
dc.date.available |
2023-11-23T05:57:08Z |
|
dc.date.issued |
2014-05 |
|
dc.identifier.uri |
https://link.springer.com/article/10.1016/j.pharep.2014.05.002 |
|
dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13229 |
|
dc.description.abstract |
Chronic unpredictable stressors can produce a situation similar to human depression and such animal models can be used for the preclinical evaluation of antidepressants. The 5-HT3 receptor antagonists modulate serotonergic pathways and show antidepressant-like effect in various animal models of depression. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Springer |
en_US |
dc.subject |
Pharmacy |
en_US |
dc.subject |
Neuropharmacological |
en_US |
dc.subject |
5-HT3 receptor antagonist |
en_US |
dc.subject |
Biochemical |
en_US |
dc.subject |
Chronic stress |
en_US |
dc.title |
Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences |
en_US |
dc.type |
Article |
en_US |